Why I Own Novocure Stock (NVCR)
Brian Orelli, biotech contributor and writer at The Motley Fool, joins the channel to discuss why he owns Novocure (NASDAQ: NVCR) stock. Check out his reasoning in this video!
*Stock prices used were the midday prices of Aug. 10, 2022. The video was published on Aug. 21, 2022.
Source Fool.com


